Chapter 8: Research, Analysis, and Evidence-Informed Practice in Substance Use Treatment

Research shapes how substance use is understood across institutions and public life. It does not simply describe trends. It influences the assumptions, responses, and systems surrounding addiction and recovery. Public narratives about substance use are shaped through political messaging, institutional priorities, and professional discourse, each of which draws on research selectively and with consequence. For students entering helping professions, developing the ability to read, evaluate, and responsibly apply research is a core competency of ethical and person-centered care.

Research serves different purposes depending on the questions being asked. Epidemiological work identifies behavioral patterns across populations. Clinical research examines whether treatment approaches appear effective under specific conditions. Qualitative research examines how individuals experience substance use within the context of trauma, identity, and daily life. Community-based research explores how structural barriers influence access to care. No single approach answers all questions, and effective practitioners draw on multiple forms of evidence.

At the same time, research should never be accepted uncritically because it contains statistics or scientific language. Data can create the appearance of neutrality while still reflecting the assumptions and priorities of the institutions that funded, designed, or disseminated it. Some populations remain underrepresented in the research base because structural barriers limit their participation or visibility.

These issues become especially important because public narratives surrounding addiction have historically been shaped by stigma, race, and criminal justice ideology. Public responses to crack cocaine during the 1980s differed significantly from responses to the opioid epidemic decades later, and media coverage of the two crises was racialized in ways that framed one primarily as a criminal problem and the other primarily as a medical one. That difference reveals how social context shapes not only substance use itself but also the way it is studied, interpreted, and discussed (Netherland & Hansen, 2016).

Evaluating where information originates is one of the most important skills students can develop. Not all sources answer the same kinds of questions, and understanding those differences shapes how evidence can be responsibly applied.

Federal agencies including the Substance Abuse and Mental Health Services Administration (SAMHSA), the Centers for Disease Control and Prevention (CDC), and the National Institute on Drug Abuse (NIDA) regularly publish reports designed to track emerging concerns connected to substance use and mental health. These sources provide broad population-level patterns but often provide only a partial picture. Large-scale surveys may exclude people experiencing incarceration, homelessness, hospitalization, or severe instability. Individuals may also underreport substance use because of stigma, fear, or legal concerns.

Peer-reviewed journal articles are evaluated by other researchers before publication in order to strengthen methodological quality. Students often assume that peer review means flawless or unbiased. In reality, it improves credibility without eliminating limitations, conflicting interpretations, or institutional influence.

Qualitative research provides a different type of understanding by focusing on lived experience, meaning, and human perception rather than statistical measurement. Where quantitative research may identify a disparity, qualitative research often helps explain how that disparity is experienced in everyday life.

Community-based and participatory research approaches have become increasingly important in behavioral health professions. These approaches involve communities directly in the research process rather than treating participants solely as subjects. Individuals with lived experience may help shape research questions, interpret findings, or guide recommendations, making lived experience part of the evidence rather than something separate from it.

Statistics carry a lot of weight in how substance use gets discussed in healthcare and policy. Numbers can help identify emerging concerns and monitor broad behavioral patterns. They can also create misleading impressions when interpreted without context or critical analysis.

One of the most common mistakes when reading research is assuming that statistics automatically explain causation. Substance use patterns typically emerge through the interaction of multiple overlapping influences rather than through a single identifiable cause. Correlation may identify connections between variables, but interpretation still requires caution.

Understanding who may be missing from the data entirely is another important consideration. Many national surveys exclude people experiencing incarceration, homelessness, or severe instability. Those gaps limit the generalizability of findings, because results from the people a survey reaches do not automatically extend to the people it misses. Statistics often reflect estimates shaped by methodological limitations rather than complete representations of reality.

Research interpretation also requires attention to language. Terms such as “abuse,” “clean,” or “addict” have historically appeared within research literature in ways that reinforce stigma. In one experimental study, clinicians who read a vignette describing a person as “a substance abuser” judged that person as more personally culpable, and more deserving of punishment, than clinicians who read the same vignette describing the person as “having a substance use disorder” (Kelly & Westerhoff, 2010).

Reading statistics critically does not mean rejecting quantitative evidence. It means recognizing that data always exist within larger social, political, and human contexts. Responsible interpretation involves asking how findings were produced, whose experiences may be missing, and how broader systems shape both the data and public responses to it.

Quantitative research is good at identifying behavioral patterns, tracking public health trends, and measuring treatment outcomes. At the same time, numbers alone rarely explain why individuals use substances, how people experience addiction, or what recovery actually feels like within everyday life.

Within substance use, qualitative research becomes especially valuable because addiction rarely develops in isolation from larger life experiences. Two individuals may share the same diagnosis while living entirely different realities. Qualitative research illuminates those differences by centering human experience rather than reducing individuals to variables within a dataset.

Qualitative approaches also help identify gaps that quantitative studies may overlook. Survey data may show lower treatment use within certain populations, but narrative research often explains why individuals avoid seeking care. Research involving marginalized communities has shown how institutional distrust and prior harmful experiences within healthcare settings can discourage treatment engagement and disclosure (Earnshaw et al., 2013).

Students entering helping professions should resist viewing research as divided into better or worse methods. Different approaches answer different kinds of questions. Effective practitioners value both forms of evidence while recognizing the strengths and limitations associated with each.

Substance use trends continue to shift alongside broader social and public health conditions. Current patterns should be understood within the context of changing social realities rather than viewed as isolated behavioral problems.

One of the most significant recent developments involves the continued rise of polysubstance use. Individuals increasingly report using multiple substances rather than engaging with one substance category alone. Many fatal overdoses now involve a stimulant used together with an opioid rather than a single drug in isolation (Ciccarone, 2021).

The opioid crisis has also kept changing. Prescription opioids shaped the early conversation, then illegally made fentanyl drove overdose deaths to record highs. More recently the picture shifted again. Total overdose deaths fell sharply from about 105,000 in 2023 to roughly 79,000 in 2024, a drop of about a quarter, driven mostly by fewer fentanyl-involved deaths (Garnett & Miniño, 2026). The numbers are encouraging, but they remain above where they stood before the pandemic, and people can still unknowingly take fentanyl through a contaminated supply. That risk continues to shape harm reduction, overdose prevention, and naloxone distribution.

As total overdose deaths fell, stimulant-involved deaths fell alongside them. Between 2023 and 2024 the age-adjusted rate of deaths involving psychostimulants with abuse potential dropped by 19.8 percent, and the rate for cocaine dropped by 26.7 percent. Opioids remained the class most often involved, appearing in 68.1 percent of the overdose deaths recorded in 2024 (Garnett & Miniño, 2026). These categories overlap, because a single death may involve more than one drug and is counted in every category that applies, so the figures cannot be added together. This matters for treatment, because stimulant use disorder has no Food and Drug Administration (FDA)-approved medication comparable to those for opioid use disorder. Clinicians are left with fewer tools for engagement, relapse prevention, and long-term support, which makes stimulant involvement in overdose deaths especially hard to respond to even as the overall death rate declines.

Social isolation has been increasingly associated with worse long-term health outcomes, including elevated risk of illness and death (Holt-Lunstad, 2021). Treatment access disparities also continue to shape outcomes significantly. Research shows that socioeconomic barriers account for much of the racial and ethnic disparity in addiction treatment completion (Saloner & Cook, 2013).

Evidence-informed practice has become a central framework within behavioral health because it recognizes that effective care requires more than applying research findings in a standardized manner. Recovery unfolds within complicated personal and structural realities that no single study can fully anticipate. Evidence-informed practice keeps care both scientifically grounded and responsive to human experience.

In substance use practice, this generally involves integrating empirical research, clinical expertise, and the lived experiences and values of individuals receiving care (SAMHSA, 2019). Research helps practitioners understand patterns related to risk and treatment engagement. Clinical expertise helps providers apply that knowledge within real-world situations. Lived experience contributes insight into the emotional and relational dimensions of addiction and recovery that research alone cannot fully capture.

Several widely used approaches reflect these principles. Motivational interviewing uses collaborative, nonjudgmental communication to strengthen a person’s own motivation for change. Harm reduction emphasizes reducing negative consequences rather than requiring immediate abstinence as the sole marker of success. Medications for opioid use disorder combine medication support with behavioral and recovery services to reduce overdose risk and improve long-term stability. Trauma-informed approaches recognize that many individuals carry histories shaped by prolonged adversity that must be understood before effective care can begin.

Personal recovery experience can provide meaningful insight without automatically translating into universally effective treatment guidance. Some individuals strongly oppose medications for opioid use disorder despite extensive evidence that buprenorphine and methadone significantly reduce overdose mortality and improve treatment retention (National Academies of Sciences, Engineering, and Medicine [NASEM], 2019). Evidence-informed practice requires practitioners to remain grounded in broader evidence rather than defaulting to a single ideological framework.

Substance use treatment history also includes approaches grounded more in ideology than in evidence. Some programs historically relied on aggressive confrontation or punitive responses to relapse despite research identifying harm associated with shame-based treatment environments (White & Miller, 2007). Good intentions alone do not guarantee ethical or effective care.

Research within substance use carries ethical implications that extend far beyond academic discussion. The way data are collected, interpreted, and applied influences public perception, treatment systems, healthcare access, and policy decisions. That responsibility for collecting, interpreting, and applying data without misrepresenting or harming the people it describes is the core of data ethics. Evidence shapes who receives compassion, who receives punishment, and which communities remain underserved.

One major ethical concern involves reducing individuals to statistics or diagnostic categories while losing sight of the human realities beneath the data. Ethical interpretation requires recognizing that numbers reflect lived experiences shaped by trauma, instability, and limited access to care. Practitioners who encounter research have a responsibility to hold both the findings and the people those findings represent.

The language used within research also carries ethical weight. Person-first terminology represents a commitment to dignity rather than a matter of style. When research or clinical communication describes people through labels rooted in criminality or moral failure, it shapes the judgments professionals make about them, including judgments about blame and punishment (Kelly & Westerhoff, 2010).

Students must also recognize the ethical risks in oversimplified public narratives. Media and political discourse often reduce substance use to personal irresponsibility while ignoring the structural realities that shape both risk and recovery. Practitioners who accept those narratives uncritically risk applying research in ways that harm the people they intend to serve.

Ethical practice further requires balancing empirical evidence with respect for lived experience. Individuals experiencing substance use disorders are not passive subjects to be managed. They are active participants in their own recovery whose values, relationships, and histories shape how healing occurs. Ethical use of research involves applying evidence in ways that strengthen dignity, autonomy, and informed decision-making rather than imposing rigid expectations about what recovery should look like.

Correlation. A relationship in which two things tend to occur together, which does not by itself mean one causes the other.

Data ethics. The responsible handling and interpretation of research and data so that it informs care without misrepresenting or harming the people it describes.

Evidence-informed practice. Practice that draws on the best available research while also weighing clinical judgment and the needs of the individual.

Generalizability. The degree to which findings from one study apply to other people, settings, or populations.

Polysubstance use. The use of more than one substance, which now appears in a large share of overdose deaths.

Qualitative research. Research that uses interviews, observation, and description to understand experience and meaning rather than counts.

Quantitative research. Research that uses numbers and measurement to describe patterns, such as how common a behavior is across a population.

Research literacy. The ability to read, evaluate, and responsibly apply research rather than taking findings at face value.

Ciccarone, D. (2021). The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Current Opinion in Psychiatry, 34(4), 344–350. https://doi.org/10.1097/YCO.0000000000000717

Earnshaw, V. A., Smith, L. R., & Copenhaver, M. M. (2013). Drug addiction stigma in the context of methadone maintenance therapy. International Journal of Mental Health and Addiction, 11(1), 110–122. https://doi.org/10.1007/s11469-012-9402-5

Garnett, M. F., & Miniño, A. M. (2026). Drug overdose deaths in the United States, 2023–2024 (NCHS Data Brief No. 549). National Center for Health Statistics. https://www.cdc.gov/nchs/products/databriefs/db549.htm

Holt-Lunstad, J. (2021). The major health implications of social connection. Current Directions in Psychological Science, 30(3), 251–259. https://doi.org/10.1177/0963721421999630

Kelly, J. F., & Westerhoff, C. M. (2010). Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. International Journal of Drug Policy, 21(3), 202–207. https://doi.org/10.1016/j.drugpo.2009.10.010

National Academies of Sciences, Engineering, and Medicine. (2019). Medications for opioid use disorder save lives. The National Academies Press. https://doi.org/10.17226/25310

Netherland, J., & Hansen, H. B. (2016). The war on drugs that wasn’t: Wasted whiteness, “dirty doctors,” and race in media coverage of prescription opioid misuse. Culture, Medicine, and Psychiatry, 40(4), 664–686. https://doi.org/10.1007/s11013-016-9496-5

Saloner, B., & Cook, B. L. (2013). Blacks and Hispanics are less likely than Whites to complete addiction treatment, largely due to socioeconomic factors. Health Affairs, 32(1), 135–145. https://doi.org/10.1377/hlthaff.2011.0983

Substance Abuse and Mental Health Services Administration. (2019). Enhancing motivation for change in substance use disorder treatment (Treatment Improvement Protocol Series No. 35, HHS Publication No. PEP19-02-01-003). https://library.samhsa.gov/product/tip-35-enhancing-motivation-change-substance-use-disorder-treatment/pep19-02-01-003

White, W. L., & Miller, W. R. (2007). The use of confrontation in addiction treatment: History, science, and time for change. Counselor, 8(4), 12–30.